Vectura Group plc Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	34
ISBN Number	not applicable
Product Code	GMD04875

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Vectura Group plc's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
3 Vectura Group plc Pipeline Products
- 3.1 Vectura Group plc Product Pipeline Analysis
  - 3.1.1 Vectura Group plc Pipeline Products By Equipment Type
  - 3.1.2 Vectura Group plc Pipeline Products By Development Stage
  - 3.1.3 Vectura Group plc Pipeline Products By Therapy Area
  - 3.1.4 Vectura Group plc Pipeline Products By News Summary
- 3.2 Duohaler
  - 3.2.1 Product Description
  - 3.2.2 Product Status
- 3.3 Duohaler
  - 3.3.1 Product Description
  - 3.3.2 Product Status
- 3.4 Budesonide Clickhaler
  - 3.4.1 Product Description
  - 3.4.2 Product Status
- 3.5 Boehringer Ingelheim Dry Powder Inhaler
  - 3.5.1 Product Description
  - 3.5.2 Product Status
  - 3.5.3 Product Milestone
4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
  - 4.2.1 Overview
5 History
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Company Statement
10 Locations And Subsidiaries
- 10.1 Head Office
11 Financial Deals Landscape
- 11.1 Acquisition
  - 11.1.1 Vectura Group acquires Innovata
12 Recent Developments
- 12.1 Strategy and Business Planning
  - 12.1.1 Dec 18, 2007: Vectura Announces Collaboration Agreement With Euroean Pharmaceutical Company
  - 12.1.2 Dec 21, 2006: Vectura Announces US Collaboration Agreement For Its Asthma Therapy
  - 12.1.3 Apr 19, 2006: Vectura Enters Agreement With Boehringer Ingelheim
- 12.2 Financial Announcements
  - 12.2.1 Apr 02, 2008: Vectura To Report Fiscal 2008 Results
  - 12.2.2 Nov 26, 2007: Vectura Reports H1 2007 Interim Results
  - 12.2.3 May 23, 2007: Vectura Declares Fiscal 2007 Preliminary Results
  - 12.2.4 Nov 17, 2006: Vectura Reports H1 Fiscal 2007 Results
  - 12.2.5 May 25, 2006: Vectura Reports Fiscal 2006 Preliminary Results
13 Appendix
- 13.1 Methodology
  - 13.1.1 Coverage
  - 13.1.2 Secondary Research
  - 13.1.3 Primary Research
  - 13.1.4 Expert Panel Validation
- 13.2 Contact Us
- 13.3 About Global Markets Direct
- 13.4 Disclaimer
List of Tables
- Table 1: Vectura Group plc,Key Facts
- Table 2: Vectura Group plc Pipeline Products by Equipment Type
- Table 3: Vectura Group plc Pipeline Products By Development Stage
- Table 4: Vectura Group plc Pipeline Products By Therapy Area
- Table 5: Vectura Group plc Pipeline Products By News Summaries
- Table 6: Vectura Group plc, Key Employees,
List of Figures
- Figure 1: Global Markets Direct Methodology